Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/194643
Title: | Genomics and epigenomics of substance use disorders: An introduction |
Author: | Cormand Rifà, Bru Cabana Domínguez, Judit Forero, Diego A. Fernàndez Castillo, Noèlia |
Keywords: | Genòmica Abús de substàncies Malalties Genomics Substance abuse Diseases |
Issue Date: | 11-May-2021 |
Publisher: | Wiley-Liss |
Abstract: | Substance use disorders (SUD) are common conditions around theworld, with important health and societal impacts, particularly inthe burden of disease (disability-adjusted life years) (Whiteford, Fer-rari, Degenhardt, Feigin, & Vos, 2015). The Global Burden of DiseaseStudy estimated the global number of cases for SUD for several sub-stances as follows: 94.8 million for alcohol, 17.2 million for amphet-amine, 15.5 million for opioids, and 13.1 million for cannabis(Whiteford, 2015). In the United States, the lifetime and 12-monthprevalences of SUD were 9.9% and 3.9%, respectively (Grantet al., 2016). In addition, polysubstance use is an important challengein the field of addiction research (Whiteford et al., 2015). |
Note: | Versió postprint del document publicat a: https://doi.org/10.1002/ajmg.b.32844 |
It is part of: | American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2021, vol. 186, num. 3, p. 125-127 |
URI: | http://hdl.handle.net/2445/194643 |
Related resource: | https://doi.org/10.1002/ajmg.b.32844 |
ISSN: | 1552-4841 |
Appears in Collections: | Articles publicats en revistes (Genètica, Microbiologia i Estadística) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
721508.pdf | 138.33 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.